chartexchange

Incyte (INCY) Halts Planned Phase 3 Ovarian Cancer Study, Citing Portfolio Prioritization

GuruFocus | Nov 16, 2026 8:00 PM EST

Company Says Decision on INCB123667 Was Not Driven by Safety or Efficacy Findings and Does Not Affect Financial Guidance Related Stocks: INCY ,

Read original article